Nebenwirkungen · Emtriva
Emtriva 10 mg/mL oral solution · Abschnitt 4.8 · PDF-Seite 19
HOS-112713 · Präparat HOS-093727
The adverse reactions with suspected (at least possible) relationship to treatment in adults from clinical trial and post-marketing experience are listed in Table 2 below by body system organ class and frequency. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Frequencies are defined as very common (≥ 1/10), common (≥ 1/100 to < 1/10) or uncommon (≥ 1/1,000 to < 1/100).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-04-18T12:34:00Z · SHA-256 4ee4f99346bca4db5449cf522784d6dbc4cba891b89d833a052a1c777428bfcb · Passage c5da1efb6f4f4070babb54dcc8451201095780787436a7dae62b30354149635e · Zeichen 1016–1442 im Abschnitt